Table III.
sMUC1 and anti-MUC1 autoantibody levels in multiple myeloma patients.
Patient no. | Patient status | sMUC1 TRA (titer)a | sMUC1 SP (titer) | Anti-MUC1 TRA Ab (μg/ml)b | Anti-MUC1 SP Ab (μg/ml)b | Anti-MUC1 TRA Ab (Positivity) | Anti-MUC1 SP Ab (Positivity) |
---|---|---|---|---|---|---|---|
1 | Active disease; under therapy | Negative | Negative | 440 | 740 | + | + |
2 | Progressive disease; under therapy | Negative | Negative | 183 | 150 | - | - |
3 | At best response; off therapy | 1:10 | Negative | 382 | 312 | + | + |
4 | Active disease; under therapy | 1:5 | Negative | 190 | 350 | - | + |
5 | Active disease; under therapy | 1:10 | Negative | 85 | 50 | - | - |
6 | Active disease; under therapy | Negative | Negative | 97 | 130 | - | - |
7 | At best response; off therapy | 1:10 | Negative | 355 | 456 | + | + |
8 | At best response; off therapy | Negative | Negative | 211 | 581 | - | + |
9 | Active disease; under therapy | Negative | Negative | 132 | 1036 | - | + |
10 | At best response; off therapy | Negative | Negative | 158 | 746 | - | + |
11 | Progressive disease; under therapy | Negative | Negative | 238 | 525 | - | + |
12 | Progressive disease; under therapy | Negative | Negative | 63 | 500 | - | + |
13 | At best response; off therapy | Negative | Negative | 500 | 1000 | + | + |
14 | Active disease; under therapy | 1:10 | Negative | 292 | 884 | + | + |
15 | Progressive disease; under therapy | 1:40 | Negative | 980 | 3400 | + | + |
16 | At best response; off therapy | Negative | Negative | 761 | 1500 | + | + |
17 | Progressive disease; under therapy | 1:20 | Negative | 91 | 100 | - | - |
18 | Progressive disease; under therapy | Negative | Negative | 728 | 424 | + | + |
19 | Progressive disease; under therapy | 1:10 | Negative | 795 | 339 | + | + |
20 | Progressive disease; under therapy | Negative | Negative | 120 | 80 | - | - |
21 | Progressive disease; under therapy | 1:20 | Negative | 3200 | 812 | + | + |
22 | Progressive disease; under therapy | Negative | Negative | 291 | 594 | + | + |
23 | Progressive disease; under therapy | Negative | Negative | 500 | 732 | + | + |
24 | Progressive disease; under therapy | 1:10 | Negative | 500 | 191 | + | - |
25 | Progressive disease; under therapy | 1:20 | Negative | 860 | 950 | + | + |
26 | Active disease; under therapy | 1:20 | Negative | 195 | 162 | - | - |
27 | Progressive disease; under therapy | 1:5 | Negative | 222 | 976 | - | + |
Percentage of patients with positive anti-MUC1 SP- and MUC1 TRA-specific antibodies levels | 14/27 | 20/27 |
Serum levels of MUC1 antigen and anti-MUC1 antibodies were measured by ELISA assay as described in Materials and methods. Positive sMUC1 level is set for titer of X>1:5.
Naïve sera for anti-MUC1 TRA antibodies epitope is X≤274μg/ml and for anti-MUC1 SP autoantibodies is X≤210.2μg/ml, based on the average plus standard deviation values determined in 15 naïve healthy individuals.